Figure 1 showed that area under receiver-operating curve (AUROC) of NPAA for differentiating lung cancer from health controls was 0.892 (95% CI, 0.874–0.961), which was higher than 0.823 (95% CI, 0.786–0.941) of VEGF. The gene discussed is VEGFA; the disease is lung carcinoma.